GLT8D2 and ovarian carcinoma: Furthermore, Annexin V assay show that the percentage of apoptotic cells in GLT8D2-overexpression ovarian cancer cells treated with CDDP was much lower compared than that in control cells, but much higher in GLT8D2-silenced cells (Fig. 2d).